Pharma Friday – September 4, 2026

September 5, 2026 - 02:30
 0  0
Pharma Friday – September 4, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer On August 26, the U.S. Food and Drug Administration (FDA) approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients […]

The post Pharma Friday – September 4, 2026 appeared first on Endocrine News.

Apa Reaksi Anda?

Suka Suka 0
Kurang Suka Kurang Suka 0
Setuju Setuju 0
Tidak Setuju Tidak Setuju 0
Bagus  Bagus 0
Berguna Berguna 0
Hebat Hebat 0
Edusehat Platform Edukasi Online Untuk Komunitas Kesehatan Agar Mendapatkan Informasi Dan Pengetahuan Terbaru Tentang Kesehatan Dari Nasional Maupun Internasional. || An online education platform for the health community to obtain the latest information and knowledge about health from both national and international sources.